Coronavirus: Commission proposes EU Strategy for the development and availability of therapeutics

Published on May 5, 2021

European Commission Press release Brussels, 06 May 2021 The European Commission is today complementing the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID'.

Continue reading on website
Other news

Handbook and appendix on Nature Based Solutions (NBS)

May 5, 2021
The Directorate-General for Research and Innovation (European Commission) published, on the 4th of May 2021, the "Handbook and appendix on Nature Based Solutions (NBS)".The Handbook aims to provide decision-makers with a comprehensive NBS impact assessment framework, and a robust set of indicators and methodologies to assess impacts of nature-based solutions across 12 societal challenge areas: Cli

EU's local and regional leaders call for patent waiver on COVID-19 vaccines

May 6, 2021
The European Committee of the Regions has called on the European Union to temporarily waive patents for vaccines against the COVID-19 virus, in order to curb the rapid spread of the pandemic. It also pressed for production in Europe to be increased and for an acceleration in the vaccination campaign across Europe.